Press ReleaseNYSE CONTENT ADVISORY: PRE-MARKET UPDATE + ANNOUNCEMENT OF NYSE TEXAS NEW YORK, Feb. 12, 2025 /PRNewswire/ — The New York Stock Exchange… CISION PRNewswireFebruary 12, 2025
Survival of the Fittest: Uneven Growth and Vendor Challenges Ahead as 2024's IoT Cellular Module Market Remained Flat NEW YORK, Feb. 12, 2025 /PRNewswire/ — Recent reports from global technology… CISION PRNewswireFebruary 12, 2025
TOYO Co., Ltd to Showcase Solar Solutions at Key Energy Industry Events TOKYO, Feb. 12, 2025 /PRNewswire/ — TOYO Co., Ltd (Nasdaq: TOYO) ("TOYO" or… CISION PRNewswireFebruary 12, 2025
U.S. MANUFACTURING PICKED UP IN JANUARY DRIVEN BY GROWING DEMAND: GEP GLOBAL SUPPLY CHAIN VOLATILITY INDEX The world’s supply chains are operating at full capacity, with the notable… CISION PRNewswireFebruary 12, 2025
Press ReleaseTriNetX and Fujitsu Launch Joint Venture to Increase Japanese Patients' Access to Life-Changing Medicines Partnership taps real-world data to accelerate clinical trials, research, and drug development… CISION PRNewswireFebruary 12, 2025
OnCusp Therapeutics Receives FDA Fast Track Designation for CUSP06 for the Treatment of Platinum-Resistant Ovarian Cancer PRINCETON, N.J., Feb. 12, 2025 /PRNewswire/ — OnCusp Therapeutics, Inc., a clinical… CISION PRNewswireFebruary 12, 2025
Press ReleaseActinogen announces peer-reviewed clinical pharmacology manuscript for Xanamem (emestedastat) published in Clinical Pharmacology in Drug Development journal Confirms the utility of the 10 mg daily oral dose of Xanamem… CISION PRNewswireFebruary 12, 2025
[Herald Interview] Fescaro CTO stresses comprehensive approach to vehicle cybersecurity SUWON, South Korea, Feb. 12, 2025 /PRNewswire/ — This is an interview… CISION PRNewswireFebruary 12, 2025
